Literature DB >> 5260227

Damage to the intrinsic cardiac neurones by rubidomycin (daunorubicin).

B Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5260227      PMCID: PMC487547          DOI: 10.1136/hrt.31.5.607

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  6 in total

1.  Daunomycin pharmacological activity at the cellular level.

Authors:  A Di Marco
Journal:  Pathol Biol       Date:  1967-10

2.  [Necropsy study of 4 patients treated with rubidomycin].

Authors:  J Ripault; M Weil; C Jacquillat
Journal:  Pathol Biol       Date:  1967-10

3.  [Cardiac complications observed during treatment with rubidomycin].

Authors:  C Macrez; H Marneffe-Lebrequier; J Ripault; J P Clauvel; C Jacquillat; M Weil
Journal:  Pathol Biol       Date:  1967-10

4.  Myenteric plexus in Hirschsprung's disease.

Authors:  B Smith
Journal:  Gut       Date:  1967-06       Impact factor: 23.059

5.  Identity of rubidomycin and daunomycin.

Authors:  G L Tong; P Lim; L Goodman
Journal:  J Pharm Sci       Date:  1967-12       Impact factor: 3.534

6.  Rubidomycin in acute leukaemia in adults.

Authors:  J S Malpas; R B Scott
Journal:  Br Med J       Date:  1968-07-27
  6 in total
  6 in total

1.  [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].

Authors:  P Obrecht; H Merker; H H Hennekeuser; G Meuret; M Westerhausen; A Simon
Journal:  Klin Wochenschr       Date:  1970-11-01

2.  Daunomycin: a cardiotoxic agent.

Authors:  L E Ainger; J Bushore; W W Johnson; J Ito
Journal:  J Natl Med Assoc       Date:  1971-07       Impact factor: 1.798

3.  Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

Authors:  Lisa A Hammond-Thelin; Melanie B Thomas; Michiko Iwasaki; James L Abbruzzese; Yvonne Lassere; Christina A Meyers; Paulo Hoff; Johann de Bono; Jody Norris; Hitoshi Matsushita; Akira Mita; Eric K Rowinsky
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

4.  Intracerebral (parenchymal) infusion of methotrexate: report of a case.

Authors:  K A Page; H Vogel; D S Horoupian
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

5.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Doxorubicin-induced cardiac neurotoxicity: study with iodine 123-labeled metaiodobenzylguanidine scintigraphy.

Authors:  J Lekakis; V Prassopoulos; P Athanassiadis; P Kostamis; S Moulopoulos
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.